1. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer
   Vittoria Manilla et al, 2023, Nutrients CrossRef
2. Triptolide inhibits intrahepatic cholangiocarcinoma growth by suppressing glycolysis via the AKT/mTOR pathway
   Li Li et al, 2023, Phytomedicine CrossRef
3. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis
   Hannes Jansson et al, 2023, European Journal of Surgical Oncology CrossRef
4. Exploring the diverse role of pyruvate kinase M2 in cancer: Navigating beyond glycolysis and the Warburg effect
   Saurabh Upadhyay et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
5. γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus
   Charupong Saengboonmee et al, 2023, World Journal of Gastroenterology CrossRef
6. Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
   Kyohei Yugawa et al, 2021, Scientific Reports CrossRef
7. Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma
   R. Connor Chick et al, 2024, Journal of Cancer Metastasis and Treatment CrossRef
8. Prognostic significance of 18F-Fluorodeoxyglucose positron-emission tomography parameters in patients with biliary tract cancers: a meta-analysis
   Xia Zheng et al, 2024, BMC Medical Imaging CrossRef